-
4,4′-(1,3-Phenylenedioxy)dianiline 2479-46-1
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Materials chemistry |Polyimide monomers |
4,4′-(1,3-Phenylenedioxy)dianiline|CAS:2479-46-1 |C18H16N2O2
-
4,4′-(4,4′-Isopropylidenediphenyl-1,1′-diyldioxy)dianiline 13080-86-9
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Industrial Material Chemistry |Polyimide monomers |4,4′-(4,4′-Isopropylidenediphenyl-1,1′-diyldioxy)dianiline |CAS:13080-86-9 |C27H26N2O2
-
(S) -3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine-1-acetic acid 1,1-dimethyl ethyl ester 109010-60-8
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Cardiovascular Diseases |High Blood Pressure |S-ATBA |CAS:109010-60-8 |C16H22N2O3
-
(R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate 1423058-53-0
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Neurologic zvirwere |Antiepileptic mishonga |(R)-2-amino-N-benzyl-3-methoxypropanamide (2R,3R)-dihydroxysuccinate |CAS:1423058-53-0 |C15H22N2O8
-
Lacosamide 175481-36-4
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Neurologic zvirwere |Antiepileptic mishonga |Lacosamide |CAS:175481-36-4 |C13H18N2O3
-
4-(2-Dimethylamino)ethoxybenzylamine 20059-73-8
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Industrial API |Digestive system mishonga |Itopride hydrochloride uye nepakati payo |4-(2-Dimethylamino)ethoxybenzylamine |CAS:20059-73-8 |C11H18N2O
-
Itopride 122898-67-3
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Industrial API |Digestive system mishonga |Itopride hydrochloride uye nepakati payo |Itopride |CAS:122898-67-3 |C20H26N2O4
-
2-(2-Ethoxyphenoxy)ethyl bromide 3259-03-8
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Industrial API |Prostatic Hyperplasia Zvinodhaka |Tamsulosin Hydrochloride Intermediates |CAS:3259-03-8 |C10H13BrO2
-
5-Acetonyl-2-methoxybenzene sulfonamide 116091-63-5
Nyanzvi yekugadzira uye kupa biopharmaceutical |Raw Materials |Pharmaceutical Intermediates Reagents |Industrial API |Prostatic Hyperplasia Zvinodhaka |Tamsulosin Hydrochloride Intermediates |CAS:116091-63-5 |C10H13NO4S
-
4-(4-Phenylbutoxy)benzoic acid 30131-16-9
Nyanzvi yekugadzira uye kupa biopharmaceutical |Pharmaceutical Intermediates Reagents |Raw materials |Zvirwere zvekufema |Pranlukast Intermediates |4-(4-Phenylbutoxy)benzoic acid |CAS:30131-16-9 |C17H18O3
-
3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone 136450-06-1
Nyanzvi yekugadzira uye kupa biopharmaceutical |Pharmaceutical Intermediates Reagents |Raw materials |Zvirwere zvekufema |Pranlukast Intermediates |3′-[4-(4-Phenylbutoxy)benzoylamino]-2′-hydroxyacetophenone |CAS:136450-06-1 |C25H25NO4
-
3'-Amino-2′-hydroxyacetophenone 70977-72-9
Nyanzvi yekugadzira uye kupa biopharmaceutical |Pharmaceutical Intermediates Reagents |Raw materials |Zvirwere zvekufema |Pranlukast Intermediates |3'-Amino-2′-hydroxyacetophenone |CAS:70977-72-9 |C8H9NO2